glycopyrrolate has been researched along with Benign Chronic Pemphigus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amir, Y; Czernik, A; Dubin, DP | 1 |
| Bindernagel, R; Kimmis, BD; Liu, D | 1 |
| Arshanapalli, A; Kaniszewska, M; Rovner, R; Tung, R | 1 |
| Blattner, CM; Elston, DM; Farahnik, B; Lear, W; Mortazie, MB; Perry, BM | 1 |
1 review(s) available for glycopyrrolate and Benign Chronic Pemphigus
| Article | Year |
|---|---|
Interventional treatments for Hailey-Hailey disease.
Topics: alpha-MSH; Antioxidants; Botulinum Toxins, Type A; Catheter Ablation; Dermabrasion; Glycopyrrolate; Humans; Laser Therapy; Muscarinic Antagonists; Neurotoxins; Pemphigus, Benign Familial; Photochemotherapy; Radiotherapy | 2017 |
3 other study(ies) available for glycopyrrolate and Benign Chronic Pemphigus
| Article | Year |
|---|---|
Botulinum Toxin and Glycopyrrolate Combination Therapy for Hailey-Hailey Disease.
Topics: Botulinum Toxins; Combined Modality Therapy; Glycopyrrolate; Humans; Pemphigus, Benign Familial | 2023 |
Use of topical 2.4% glycopyrronium tosylate in familial benign pemphigus (Hailey-Hailey disease).
Topics: Administration, Topical; Cholinergic Antagonists; Constipation; Drug Administration Schedule; Glycopyrrolate; Humans; Male; Middle Aged; Pemphigus, Benign Familial; Scrotum; Xerostomia | 2020 |
Oral glycopyrrolate for the treatment of Hailey-Hailey disease.
Topics: Administration, Oral; Follow-Up Studies; Glycopyrrolate; Humans; Male; Middle Aged; Muscarinic Antagonists; Pemphigus, Benign Familial; Treatment Outcome | 2015 |